Could social prescribing contribute to type 2 diabetes prevention in people at high risk? Protocol for a realist, multilevel, mixed methods review and evaluation
Introduction Social prescribing is an innovation being widely adopted within the UK National Health Service policy as a way of improving the management of people with long-term conditions, such as type 2 diabetes (T2D). It generally involves linking patients in primary care with non-medical communit...
Main Authors: | Trisha Greenhalgh, Megan Clinch, Sarah Finer, Sara Calderón-Larrañaga |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-04-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/11/4/e042303.full |
Similar Items
-
Tensions and opportunities in social prescribing. Developing a framework to facilitate its implementation and evaluation in primary care: a realist review
by: Sara Calderón-Larrañaga, et al.
Published: (2021-05-01) -
Protocol - realist and meta-narrative evidence synthesis: Evolving Standards (RAMESES)
by: Westhorp Gill, et al.
Published: (2011-08-01) -
Social prescribing for people with complex needs: a realist evaluation
by: Emily Wood, et al.
Published: (2021-03-01) -
Internet-based medical education: a realist review of what works, for whom and in what circumstances
by: Greenhalgh Trisha, et al.
Published: (2010-02-01) -
Supporting social prescribing in primary care by linking people to local assets: a realist review
by: Stephanie Tierney, et al.
Published: (2020-03-01)